Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S

Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212

Authors: Julian-Reynier, C Eisinger, F Chabal, F Aurran, Y Bignon, YJ Machelard-Roumagnac, M Maugard, C Nogues, C Vennin, P Sobol, H

Citation: C. Julian-reynier et al., Cancer genetic consultation and anxiety in healthy consultees, PSYCHOL HEA, 14(3), 1999, pp. 379-390

Authors: Ray-Coquard, I Le Cesne, A Rubio, MT Mermet, J Maugard, C Ravaud, A Chevreau, C Sebban, C Bachelot, T Biron, P Blay, JY

Citation: I. Ray-coquard et al., Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens, J CL ONCOL, 17(9), 1999, pp. 2840-2846

Authors: Wang, Q Lasset, C Desseigne, F Saurin, JC Maugard, C Navarro, C Ruano, E Descos, L Trillet-Lenoir, V Bosset, JF Puisieux, A

Citation: Q. Wang et al., Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer, HUM GENET, 105(1-2), 1999, pp. 79-85

Authors: Chevreau, C Bui, BN Chevallier, B Krakowski, I Maugard, C Mihura, J Coindre, JM Gil, B Cour-Chabernaud, V

Citation: C. Chevreau et al., Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS), AM J CL ONC, 22(3), 1999, pp. 267-272